交易中 09-20 10:34:32 美东时间
-0.127
-1.44%
Piper Sandler analyst Jessica Tassan maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target from $14 to $11.
08-26 23:36
Health Catalyst Inc : Piper Sandler Cuts Target Price to $11 From $14
08-26 12:18
Across the recent three months, 5 analysts have shared their insights on Health...
08-10 02:02
多只小盘绩优股隔夜暴涨!Digital Turbine涨61.8%,Q2业绩超市场预期;Sezzle隔夜涨35.1%,提高全年收入指引>>
08-09 20:12
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-09 01:08
Richard Close, an analyst from Canaccord Genuity, maintained the Buy rating on ...
08-08 20:59
SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Cat...
08-08 20:00
Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon
08-08 20:00
Health Catalyst Inc - Funds Transaction With Stock and Cash
08-08 20:00
SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizat...
08-08 20:00